Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro

被引：0
|
作者：
Selvi Kunnimalaiyaan
Victoriana K. Schwartz
Iris Alao Jackson
T. Clark Gamblin
Muthusamy Kunnimalaiyaan
机构：
[1] Division of Surgical Oncology,
[2] Department of Surgery,undefined
[3] Medical College of Wisconsin,undefined
[4] C4763,undefined
[5] Translational and Biomedical Research Center,undefined
来源：
BMC Cancer | / 18卷
关键词：
GSK-3 inhibitor; Neuroblastoma; GSK-3 alpha; GSK-3 beta; Apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Orally bioavailable GSK-3α/β dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo
    Kulkarni, Nalini H.
    Onyia, Jude E.
    Zeng, QingQiang
    Tian, Xioayan
    Liu, Min
    Halladay, David L.
    Frolik, Charles A.
    Engler, Thomas
    Wei, Tao
    Kriauciunas, Aidas
    Martin, T. John
    Sato, Masahiko
    Bryant, Henry U.
    Ma, Yanfei L.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (06) : 910 - 920
  • [32] Development of a GSK-3 inhibitor as a potential treatment for Alzheimer's disease
    Del Ser, T.
    Andres, M. V.
    Vericat, J. A.
    Martinez, A.
    Medina, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 33 - 33
  • [33] A unique type of GSK-3 inhibitor brings new opportunities to the clinic
    Licht-Murava, Avital
    Paz, Rom
    Vaks, Lilach
    Avrahami, Limor
    Plotkin, Batya
    Eisenstein, Miriam
    Eldar-Finkelman, Hagit
    SCIENCE SIGNALING, 2016, 9 (454)
  • [34] A new GSK-3β inhibitor with in vivo activity in models of mood disorders
    Garrone, B.
    Reggiani, A.
    Capurro, V.
    Lanfranco, M.
    Summa, M.
    Di Giorgio, F. P.
    Tongiani, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S377 - S378
  • [35] Stimulation of bone formation in the expanding premaxillary suture with a GSK-3β inhibitor
    Jiang, Y.
    Liu, H. X.
    Guo, J. J.
    Tang, G. H.
    Qian, Y. F.
    ORAL DISEASES, 2013, 19 (01) : 73 - 79
  • [36] Strain differences in GSK-3β phosphorylation:: Effect of citalopram
    Pozzi, L.
    Sacchetti, G.
    Calcagno, E.
    Invernizzi, R. W.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S75 - S75
  • [37] A GSK-3β Inhibitor Protects Against Radiation Necrosis in Mouse Brain
    Jiang, Xiaoyu
    Perez-Torres, Carlos J.
    Thotala, Dinesh
    Engelbach, John A.
    Yuan, Liya
    Cates, Jeremy
    Gao, Feng
    Drzymala, Robert E.
    Rich, Keith M.
    Schmidt, Robert E.
    Ackerman, Joseph J. H.
    Hallahan, Dennis E.
    Garbow, Joel R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (04): : 714 - 721
  • [38] Nordentatin Inhibits Neuroblastoma Cell Proliferation and Migration through Regulation of GSK-3 Pathway
    Boonyarat, Chantana
    Boonput, Panatchakorn
    Tongloh, Nantakorn
    Kaewamatawong, Rawiwun
    Chaiwiwatrakul, Suchada
    Yenjai, Chavi
    Waiwut, Pornthip
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (03) : 1062 - 1074
  • [39] Biochemical characterization of phospholipids, sulfatide and heparin as potent stimulators for autophosphorylation of GSK-3β and the GSK-3β-mediated phosphorylation of myelin basic protein in vitro
    Kawakami, Fumitaka
    Yamaguchi, Akira
    Suzuki, Kanzo
    Yamamoto, Takayuki
    Ohtsuki, Kenzo
    JOURNAL OF BIOCHEMISTRY, 2008, 143 (03): : 359 - 367
  • [40] In vitro evaluation of the effects of potential GSK-3β inhibitors terbutaline and orciprenaline
    Uzunhisarcikli, Ebru
    TRAKYA UNIVERSITY JOURNAL OF NATURAL SCIENCES, 2024, 25 (01) : 73 - 80
12345